Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial
Related Posts
Menuet C, Ben-Tal A, Linossier A, Allen AM, Machado BH, Moraes DJA, Farmer DGS, Paterson DJ, Mendelowitz D, Lakatta EG, Taylor EW, Ackland GL, Zucker[...]
Zhou Z, Moore TM, Strumwasser AR, Ribas V, Iwasaki H, Morrow N, Ma A, Tran PH, Wanagat J, de Aguiar Vallim TQ, Clifford B, Zhang[...]
Moore JP, Ghantous E, Waldmann V, Bessière F, Babouri N, Cohen MI, O'Leary ET, Patel NS, Nazer B, Tan W, Fish FA, Dalal AS, Mariucci[...]